Showing results (161-170 of 396) with videos related to

Sort By:
Pageof 40
Hepatology (Baltimore, Md.)|February 16, 2012
Fatty liver index, gamma-glutamyltransferase, and early carotid plaquesMichaela Kozakova, Carlo Palombo, Marco Paterni Eng, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidismAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
European Journal of Endocrinology|March 5, 2005
Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditisAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
Cytokine|May 16, 2006
Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageingAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
Pediatric Diabetes|January 23, 2016
Differences in β-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role?Sara F Michaliszyn, SoJung Lee, Fida Bacha, et al.
Diabetologia|July 31, 2015
Mechanisms through which a small protein and lipid preload improves glucose toleranceDomenico Tricò, Simona Baldi, Alberto Tulipani, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 25, 2019
Renal hemodynamics and fatty acid uptake: effects of obesity and weight lossEleni Rebelos, Prince Dadson, Vesa Oikonen, et al.
Diabetes Care|May 27, 2004
Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetesAndrea Natali, Stephanie Baldeweg, Elena Toschi, et al.
European Journal of Endocrinology|April 29, 2006
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory processAlessandro Antonelli, Poupak Fallahi, Mario Rotondi, et al.
Clinical Endocrinology|January 25, 2006
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapyAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
Pageof 40